✦ LIBER ✦

Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany

✍ Scribed by B. Brüggenjürgen; P. Lindgren; B. Ehlken; H.-J. Rupprecht; S. N. Willich

Publisher: Springer
Year: 2006
Tongue: French
Weight: 178 KB
Volume: 8
Category: Article
ISSN: 1618-7598
DOI: 10.1007/s10198-006-0006-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute Coronary Syndrome in Patients Pres

Acute Coronary Syndrome in Patients Presenting with ST-Segment Elevation

✍ Kurt J. G. Schmailzl; Frank Hölschermann; Torsten Schwalm; Enrico Wilke 📂 Article 📅 2003 🏛 Springer Vienna 🌐 German ⚖ 167 KB

Efficacy and safety of optimized antithr

Efficacy and safety of optimized antithrombotic therapy with aspirin, clopidogrel and enoxaparin in patients with non-ST segment elevation acute coronary syndromes in clinical practice

✍ Tobias Heer; Claus Juenger; Anselm K. Gitt; Timm Bauer; Frank Towae; Ralf Zahn; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 243 KB

Eptifibatide does not suppress the incre

Eptifibatide does not suppress the increase of inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome

✍ Alexey A. Mazaev; Yaroslav A. Naimushin; Valery P. Masenko; Mikhail Y. Ruda; Ale 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 205 KB

Utilization of catheterization and revas

Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade

✍ Glenn N. Levine; A. Michael Lincoff; James J. Ferguson III; Kenneth W. Mahaffey; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB 👁 1 views

Coronary collaterals reduce microvascula

Coronary collaterals reduce microvascular obstruction and improve long-term survival in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention

✍ Steffen Desch; Ingo Eitel; Gerhard Schuler; Holger Thiele 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 66 KB

Balancing the benefits and risks of anti

Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention

✍ Jorge F. Saucedo 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 349 KB